dexamethasone,lenalidomide,bortezomib
takeda
['determination']
live: #plenary at #asco22 - paul richardson presents the results of the determination study: rvd + asct significantly superior to rvd alone for pfs in nd #myeloma, no difference in os. key findings: also published in today: 
Haematologist | PhD Researcher | Humanist | Musician | Stem Cell Transplantation | Cellular Therapies | HSANZ/Leukaemia Foundation PhD Scholar